Sector
PharmaceuticalsOpen
₹663Prev. Close
₹667.45Turnover(Lac.)
₹1.48Day's High
₹663Day's Low
₹660.952 Week's High
₹99952 Week's Low
₹356.5Book Value
₹570.15Face Value
₹10Mkt Cap (₹ Cr.)
235.99P/E
8.77EPS
76.14Divi. Yield
012 Jul 2024
12:00 AM
Dividend
Dividend Amount: 2
19 Aug 2024
12:00 AM
AGM
Announcement Date: 19 Aug, 2024
5 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
19 Aug 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3.57 | 3.57 | 3.57 | 3.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 173.92 | 151.23 | 152.48 | 133.07 |
Net Worth | 177.49 | 154.8 | 156.05 | 136.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 96.56 | 70.57 | 92.47 | 95.47 |
yoy growth (%) | 36.82 | -23.67 | -3.13 | 23.96 |
Raw materials | -50.06 | -40.02 | -53.57 | -48.67 |
As % of sales | 51.84 | 56.71 | 57.93 | 50.98 |
Employee costs | -10.18 | -9.7 | -8.56 | -6.75 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 17.59 | 9.11 | 18.04 | 24.88 |
Depreciation | -1.98 | -2 | -1.56 | -1.55 |
Tax paid | -4.05 | -1.98 | -5.6 | -8.26 |
Working capital | 11.57 | 22.79 | -3.33 | 10.21 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.82 | -23.67 | -3.13 | 23.96 |
Op profit growth | 199.58 | -65.14 | -34.33 | 41.59 |
EBIT growth | 92.21 | -49.25 | -27.44 | 42.53 |
Net profit growth | 90.09 | -42.7 | -23.62 | 31.45 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Girish Dhameja
Director & CFO
Sushma Shashi Kadkade
Independent Director
Saurabh Shah
Independent Director
Malay Doshi
Non Executive Director
Rajendrasinh Rana
Company Sec. & Compli. Officer
Dhwani Desai
Independent Director
Pooja Hindia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Coral Laboratories Ltd
Summary
Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group. To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company went into public issue in March 94 at a total cost of Rs.2.5 crores. It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004. It started the commercial production at Dehradun Plant in September, 2006.
Read More
What is the Coral Laboratories Ltd share price today?
The Coral Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹661.05 today.
What is the Market Cap of Coral Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Coral Laboratories Ltd is ₹235.99 Cr. as of 09 May ‘25
What is the PE and PB ratio of Coral Laboratories Ltd?
The PE and PB ratios of Coral Laboratories Ltd is 8.77 and 1.17 as of 09 May ‘25
What is the 52 Week High and Low of Coral Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Coral Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Coral Laboratories Ltd is ₹356.5 and ₹999 as of 09 May ‘25
What is the CAGR of Coral Laboratories Ltd?
Coral Laboratories Ltd's CAGR for 5 Years at 36.51%, 3 Years at 37.46%, 1 Year at 77.51%, 6 Month at -23.06%, 3 Month at -12.81% and 1 Month at -0.38%.
What is the shareholding pattern of Coral Laboratories Ltd?
The shareholding pattern of Coral Laboratories Ltd is as follows:
Promoters - 71.51 %
Institutions - 0.00 %
Public - 28.49 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
